I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
de Jonge, Maja
248
results:
Search for persons
X
Format
Online (248)
Mediatypes
Articles (Online) (75)
Bookchapter (Online) (2)
OpenAccess-fulltext (171)
Sorted by: Relevance
Sorted by: Year
?
1
First-in-human study of naporafenib (LXH254) with or withou..:
Janku, Filip
;
Kim, Tae Min
;
Iyer, Gopakumar
...
European Journal of Cancer. 196 (2024) - p. 113458 , 2024
Link:
https://doi.org/10.1016/..
?
2
Patient values in patient-provider communication about part..:
van Lent, Liza G. G.
;
van der Ham, Mirte
;
de Jonge, Maja J. A.
...
BMC Medical Informatics and Decision Making. 24 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1186/..
?
3
The development of brain metastases in patients with differ..:
Derks, Sophie H. A. E.
;
van der Meer, Edgar L.
;
Joosse, Arjen
...
International Journal of Cancer. 155 (2024) 6 - p. 1045-1052 , 2024
Link:
https://doi.org/10.1002/..
?
4
Comprehensive characterization of circulating tumor cells a..:
Bos, Manouk K.
;
Kraan, Jaco
;
Starmans, Martijn P. A.
...
Molecular Oncology. , 2024
Link:
https://doi.org/10.1002/..
?
5
Olaparib and durvalumab in patients with relapsed small cel..:
Krebs, Matthew G.
;
Delord, Jean-Pierre
;
Jeffry Evans, Thomas R.
...
Lung Cancer. 180 (2023) - p. 107216 , 2023
Link:
https://doi.org/10.1016/..
?
6
Pharmacokinetics and immunogenicity of eftozanermin alfa in..:
Biesdorf, Carla
;
Guan, Xiaowen
;
Siddani, Satya R.
...
Cancer Chemotherapy and Pharmacology. , 2023
Link:
https://doi.org/10.1007/..
?
7
Impact of Novel Treatments in Patients with Melanoma Brain ..:
Derks, Sophie H. A. E.
;
Jongen, Joost L. M.
;
van der Meer, Edgar L.
...
Cancers. 15 (2023) 5 - p. 1461 , 2023
Link:
https://doi.org/10.3390/..
?
8
Efficacy, safety and biomarker analysis of durvalumab in pa..:
Geurts, Birgit S.
;
Battaglia, Thomas W.
;
van Berge Henegouwen, J. Maxime
...
BMC Cancer. 23 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
9
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancer..:
Subbiah, Vivek
;
Kreitman, Robert J.
;
Wainberg, Zev A.
...
Nature Medicine. 29 (2023) 5 - p. 1103-1112 , 2023
Link:
https://doi.org/10.1038/..
?
10
NCMP-01. TREATMENT STRATEGIES IN PATIENTS WITH RENAL CELL C..:
Derks, Sophie
;
van der Meer, Edgar
;
Joosse, Arjen
...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v206-v207 , 2023
Link:
https://doi.org/10.1093/..
?
11
Olaparib plus Durvalumab, with or without Bevacizumab, as T..:
Drew, Yvette
;
Kim, Jae-Weon
;
Penson, Richard T.
...
Clinical Cancer Research. 30 (2023) 1 - p. 50-62 , 2023
Link:
https://doi.org/10.1158/..
?
12
Dabrafenib plus trametinib in patients with relapsed/refrac..:
Kreitman, Robert J.
;
Moreau, Philippe
;
Ravandi, Farhad
...
Blood. 141 (2023) 9 - p. 996-1006 , 2023
Link:
https://doi.org/10.1182/..
?
13
Core values of patients with advanced cancer considering pa..:
van Gurp, Jelle L. P.
;
van Lent, Liza G. G.
;
Stoel, Nicole
...
Supportive Care in Cancer. 30 (2022) 9 - p. 7605-7613 , 2022
Link:
https://doi.org/10.1007/..
?
14
Eftozanermin alfa (ABBV-621) monotherapy in patients with p..:
LoRusso, Patricia
;
Ratain, Mark J.
;
Doi, Toshihiko
...
Investigational New Drugs. 40 (2022) 4 - p. 762-772 , 2022
Link:
https://doi.org/10.1007/..
?
15
First-in-man, first-in-class phase I study with the monopol..:
Schöffski, Patrick
;
Awada, Ahmad
;
de la Bigne, Anne-Marie
...
European Journal of Cancer. 169 (2022) - p. 135-145 , 2022
Link:
https://doi.org/10.1016/..
1-15